SCREENING FOR COLORECTAL-CANCER IN MARKET-HARBOROUGH, UK - A COMMUNITY-BASED PROGRAM

被引:10
作者
HART, AR
GAY, SP
DONNELLY, A
GRIFFIN, L
INGLIS, A
MAYBERRY, MK
WICKS, ACB
MAYBERRY, JF
机构
[1] Gastroenterology Research Unit, Leicester General Hospital, Leicester
[2] Market Harborough Medical Centre, Market Harborough, Leicestershire
关键词
COLORECTAL CANCER; SCREENING; COMMUNITY; COMPLIANCE;
D O I
10.1097/00042737-199406000-00012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: To identify those groups of people who fail to participate in colorectal cancer screening programmes, using faecal occult blood tests, and to determine areas of diagnostic delay within such programmes. Design: General practitioners in Market Harborough, Leicestershire, UK, offered 4176 people aged from 50-70 years, registered with the practice, a free haemoccult test for the early detection of colorectal cancer. Methods: Compliance was measured according to age and gender. Those patients with positive faecal occult blood tests were investigated with colonoscopy. Results: The compliance rate was 38%, with more women participating than men (42 compared with 33%, chi2 = 37.2, P < 0.0001). This difference was due to younger women, aged 50-60 years, returning more kits than their male counterparts (47 compared with 32%, chi2 = 54.7, P < 0.0001). Two patients were diagnosed as having carcinoma (Dukes' C and D tumours) and a further four as having adenomatous polyps. Patients were allowed 1 month to complete repeat tests while on a restricted diet and to decide whether to undergo investigation. Conclusions: To achieve a high compliance rate in future programmes, all groups should be targeted, especially men and older women. In patients with positive initial tests found to have distal lesions, diagnosis may be advanced by an immediate rectal examination and rigid sigmoidoscopy.
引用
收藏
页码:519 / 522
页数:4
相关论文
共 19 条
[1]  
Mortality Statistics, (1990)
[2]  
Gill P.G., Morris P.J., The survival of patients with colorectal cancer treated in a regional hospital, Br J Suxsrg, 65, pp. 17-20, (1978)
[3]  
Stower M.J., Hardcastle J.D., The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital, Eur J Surg Oncol, 11, pp. 119-123, (1985)
[4]  
Hardcastle J.D., Chamberlain J., Sheffield J., Balfour T.W., Armitage N.C., Thomas W.M., Et al., Randomised controlled trial of faecal occult blood screening for colorectal cancer, Lancet, 1, pp. 1160-1164, (1989)
[5]  
Thomas W.M., Hardcastle J.D., An update on the Nottingham trial of faecal occult blood screening for colorectal carcinoma, Cancer Screening, pp. 106-115, (1991)
[6]  
Kronborg O., Fenger C., Sondergaard O., Pederson K.M., Olsen J., Initial mass screening for colorectal cancer with faecal occult blood, Scand J Gastroenterol, 22, pp. 677-686, (1987)
[7]  
Kewenter J., Asztely M., Engaras B., Hagland E., Svanvik J., Ahren C., A randomised trial of faecal occult blood testing for early detection of colorectal cancer, Cancer Screening, pp. 116-125, (1991)
[8]  
Winawer S.J., Schottenfeld D., Flehinger B.J., Colorectal cancer screening, J Natl Cancer Inst, 83, pp. 243-253, (1991)
[9]  
Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., Et al., Reducing mortality from colorectal cancer by screening for faecal occult blood, N Engl J Med, 328, pp. 1365-1371, (1993)
[10]  
Thomas W.M., Pye G., Hardcastle J.D., Chamberlain J., Charnley R.M., Role of dietary restriction in haemoccult screening for colorectal cancer, Br J Surg, 76, pp. 976-978, (1989)